Jens Peter Kampmann

Learn More
There is little research-based documentation on the services provided by drug information centres (DICs). The aim of this multi-centre study was to explore for the first time the factors associated with time consumption when answering drug-related queries at eight different but comparable DICs. During an 8-week period, staff members at eight Scandinavian(More)
PURPOSE The aims of this study were to assess the quality of responses produced by drug information centers (DICs) in Scandinavia, and to study the association between time consumption processing queries and the quality of the responses. METHODS We posed six identical drug-related queries to seven DICs in Scandinavia, and the time consumption required for(More)
Recommendations for treatment with specific antidementia drugs in Denmark are given on the basis of recent evidence. Such evidence supports treatment of mild to moderate Alzheimer's Disease (AD) with acetylcholinesterase inhibitors (AchEI), and moderate to severe AD with memantine. Combination therapy with these drugs can be considered in moderate AD.(More)
  • 1